In recent trading session, Colgate-Palmolive Co (NYSE:CL) saw 0.88 million shares changing hands at last check today with its beta currently measuring 0.36. Company’s recent per share price level of $89.00 trading at $1.43 or 1.63% at last check today assigns it a market valuation of $72.13B. That most recent trading price of CL’s stock is at a discount of -22.81% from its 52-week high price of $109.30 and is indicating a premium of 4.13% from its 52-week low price of $85.32. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 4.35 million shares which gives us an average trading volume of 5.60 million if we extend that period to 3-months.
For Colgate-Palmolive Co (CL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.13. Splitting up the data highlights that, out of 17 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 5 suggested the stock as a Hold whereas 12 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.9 in the current quarter.
Colgate-Palmolive Co (NYSE:CL) trade information
Upright in the green today for gaining 1.63%, in the last five days CL remained trading in the red while hitting it’s week-highest on Friday, 05/09/25 when the stock touched $89.00 price level, adding 2.15% to its value on the day. Colgate-Palmolive Co’s shares saw a change of -2.10% in year-to-date performance and have moved -2.01% in past 5-day. Colgate-Palmolive Co (NYSE:CL) showed a performance of -5.58% in past 30-days. Number of shares sold short was 12.02 million shares which calculate 1.86 days to cover the short interests.
Analysts have been projecting 89 as a low price target for the stock while placing it at a high target of 89.
Colgate-Palmolive Co (CL) estimates and forecasts
This year revenue growth is estimated to rise 0.84% from the last financial year’s standing.
12 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 5.03B for the same. And 12 analysts are in estimates of company making revenue of 5.16B in the next quarter. Company posted 5.06B and 5.03B of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 5.01% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 1.59% while estimates for its earnings growth in next 5 years are of 5.48%.
CL Dividends
Colgate-Palmolive Co is more likely to be releasing its next quarterly report on 2025-Apr-24 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt. With an annual yield of 2.27%, the share has a forward dividend of 2.02 which implies that company’s dividend yield remained growing in trailing twelve months while having a 5 year average dividend yield of 2.28%.
Colgate-Palmolive Co (NYSE:CL)’s Major holders
Insiders are in possession of 0.15% of company’s total shares while institution are holding 87.02 percent of that, with stock having share float percentage of 87.15%. Investors also watch the number of corporate investors in a company very closely, which is 87.02% institutions for Colgate-Palmolive Co that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at CL for having 80.32 million shares of worth $7.79 billion. And as of 2024-06-30, it was holding 9.7983 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 61.62 million shares on 2024-06-30. The number of shares represents firm’s hold over 7.517 of outstanding shares, having a total worth of $5.98 billion.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 25.56 shares of worth $2.27 billion or 3.15% of the total outstanding shares. The later fund manager was in possession of 22.12 shares on Dec 31, 2024 , making its stake of worth around $1.97 billion in the company or a holder of 2.73% of company’s stock.
